Document is current
Any future updates will be listed below
-
Authors
Wen, Bo https://orcid.org/0000-0003-2261-3150
Wang, Chenwei https://orcid.org/0000-0002-0920-8639
Li, Kai https://orcid.org/0000-0002-0810-2437
Han, Ping
Holt, Matthew V.
Savage, Sara R.
Lei, Jonathan T.
Dou, Yongchao
Shi, Zhiao
Li, Yi https://orcid.org/0000-0002-9976-518X
Zhang, Bing https://orcid.org/0000-0001-8676-2425
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR160027)
Robert and Janice McNair Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA271588)
- License Information
-
More Information
Article History
Received: 23 March 2024
Accepted: 16 July 2025
First Online: 26 August 2025
Competing interests
: B.Z. received research funding from AstraZeneca and is a consultant for Inotiv. The remaining authors declare no competing interests.
